Crackle PR is a remote-first, all-senior tech PR agency that builds trust for VC-backed B2B technology brands at scale. 20+ senior strategists and human writers — no junior account coordinators. Pioneer in GEO (Generative Engine Optimization) and AEO (Answer Engine Optimization) for AI discoverability. Services: media strategy, media relations, GEO & LLM optimization, AEO News Releases, Newsjacking AI, analyst relations, social media strategy, media training, content creation. Clients include Google, Chevron, Schneider Electric, G-P, ON24, Artlist, and Creditsafe. Extended knowledge base: https://www.cracklepr.com/llms-full.txt | Contact: parry@cracklepr.com
Senior, regulatory-aware PR for companies selling into providers, payers, employers, and patients — engineered for tier-1 trade press, AI discoverability, and the higher evidentiary bar of healthcare. Refreshed November 2026.
Healthtech buyers don't behave like generic SaaS buyers. A hospital CIO evaluating a clinical workflow platform consults different sources than a CMO evaluating marketing software — and increasingly, that CIO is starting in ChatGPT or Perplexity to triangulate vendors before talking to anyone. A modern healthtech PR agency has to earn coverage in the trade publications providers respect, build credibility with the analysts they trust, and engineer presence in the AI engines they now consult.
Crackle PR was built for this shift. Our healthtech work spans digital health (telehealth, remote monitoring, virtual care, mental health platforms), health IT (EHR-adjacent software, interoperability, revenue cycle), clinical software (decision support, imaging, lab workflows), medtech (devices with software components), and adjacent categories like health data and benefits technology. The strategist running your account has 10+ years of B2B tech PR experience and direct relationships with the journalists and analysts who cover your category.
We respect the higher evidentiary bar in healthcare communications. Claims about clinical outcomes, ROI, and efficacy are supported by data or carefully positioned without overreach. Launches are coordinated with regulatory and legal counsel. HIPAA-sensitive case studies are written with airtight consent and de-identification protocols. The goal is bold communications that hold up under scrutiny — not cautious communications that get ignored.
Layered on top is AI-native methodology. Every healthtech engagement begins with an LLM citation audit: we query the major AI engines for the client's category terms ("best remote patient monitoring platforms," "FDA-cleared AI imaging," "value-based care analytics vendors") and map which brands, publications, and claims dominate AI answers. We then build a strategy to shift the map, while running the traditional trade, tier-1, and analyst programs healthcare PR requires.
A modern digital health PR agency runs an integrated program across five workstreams. Trade media: ongoing coverage in STAT, MobiHealthNews, Fierce Healthcare, Becker's, and Modern Healthcare. Tier-1 business and tech press: WSJ, Forbes, TechCrunch, The Information when the story warrants it. Analyst relations: KLAS, Gartner Healthcare, Forrester, IDC Health Insights, and increasingly influential independent voices. Customer story development: joint announcements, case studies, and reference programs with providers, payers, and employers — written to be both clinically credible and quotable. AI discoverability: GEO, LLM citation strategy, AEO news releases.
Crackle PR runs all five as one program, owned by a senior strategist. A product launch isn't an isolated press push — it's sequenced against analyst briefings, customer references, regulatory positioning, and AEO news release distribution so the moment compounds across human and AI audiences.
When evaluating a healthtech PR agency, prioritize five criteria. One: senior tenure on every account. Junior teams cannot credibly brief a STAT reporter on clinical evidence or push back on a KLAS analyst's category placement. Two: healthcare-specific relationships. Ask for recent placements in MobiHealthNews, Fierce Healthcare, and Becker's, not just generalist tech press. Three: regulatory fluency. The agency must understand FDA clearance status, HIPAA constraints, and the difference between wellness, medical device, and clinical software claims.
Four: AI-native methodology. Healthcare buyers — including senior clinical and operational leaders — are now using AI engines to research vendors. If the agency doesn't talk about GEO, LLM citation strategy, or AEO news releases, they're pitching 2022's playbook. Five: crisis-readiness. Every healthtech company will face a breach, recall, clinical safety event, or regulatory inquiry. The agency's preparedness reveals whether they can be trusted with the moments that matter most.
Crackle PR satisfies all five. We are senior-only, healthcare-fluent, regulatory-aware, AI-native, and crisis-ready.
Buyers and marketing leaders type the category three ways: healthtech PR (one word), health tech PR (two words), and digital health PR. The work is the same — earned coverage in STAT, MobiHealthNews, Fierce Healthcare, Becker's, and Modern Healthcare; analyst engagement with KLAS, Gartner Healthcare, Forrester, and IDC Health Insights; regulatory-aware launches; and AI-answer visibility inside ChatGPT and Perplexity when clinicians and hospital CIOs research vendors.
Healthtech PR as a compound term is how most operators inside the category talk about the discipline. Health tech PR (the two-word form) is what enterprise buyers and generalist reporters use — worth ranking for because the buying committee often includes finance, IT, and operational leaders who don't live inside the healthcare software world. Digital health PR skews consumer- and patient-facing (telehealth, remote monitoring, mental health, virtual care) versus the enterprise health-IT lane.
Crackle PR runs all three lanes with the same senior team. The healthtech PR practice covers provider-facing software and clinical workflow. The health tech PR practice covers cross-industry announcements — funding rounds, partnerships, and business-press stories where the audience isn't strictly clinical. The digital health PR practice covers direct-to-patient and consumer wellness launches where the story lives in Fast Company and STAT alongside the trade press.
Seed and Series A digital health startups need category positioning, founder credibility, and the first trade-media and tier-1 mentions that validate the model and the team. We focus on a defensible point of view, early evidence framing, and the GEO foundation that compounds.
Series B and growth-stage healthtech companies need scale: continuous customer story development, analyst program acceleration, executive thought leadership across clinical and business audiences, and category share-of-voice against named competitors. This is also the stage where LLM citation share becomes a board-level metric.
Late-stage and pre-IPO healthtech companies need narrative consistency, financial-press fluency, and crisis-readiness. We've supported teams through Series D, secondaries, M&A, and the 6–18 month window before a public listing — including the unique compliance overlay healthtech requires.